Skip to content
10-K/A

Annual Report

INTERLEUKIN GENETICS INC

0001144204-17-020895

← back to feed
Filed
Apr 18, 2017 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2016 · Apr 13, 2017 229.47M sh
Capex FY 2016 · Dec 31, 2016 $84.86K
Capex FY 2016 · Dec 31, 2015 $82.49K
Long Term Debt FY 2016 · Dec 31, 2016 $1.13M
Long Term Debt FY 2016 · Dec 31, 2015 $3.47M
Short Term Debt FY 2016 · Dec 31, 2016 $2.3M
Short Term Debt FY 2016 · Dec 31, 2015 $1.33M
Cash And Equivalents FY 2016 · Dec 31, 2016 $2.66M
Cash And Equivalents FY 2016 · Dec 31, 2015 $4.71M
Cash And Equivalents FY 2016 · Dec 31, 2014 $11.47M
Stockholders Equity FY 2016 · Dec 31, 2016 −$2.85M
Stockholders Equity FY 2016 · Dec 31, 2015 −$2.46M
Current Liabilities FY 2016 · Dec 31, 2016 $5.55M
Current Liabilities FY 2016 · Dec 31, 2015 $5.48M
Total Liabilities FY 2016 · Dec 31, 2016 $6.68M
Total Liabilities FY 2016 · Dec 31, 2015 $8.95M
Current Assets FY 2016 · Dec 31, 2016 $3.27M
Current Assets FY 2016 · Dec 31, 2015 $5.7M
Total Assets FY 2016 · Dec 31, 2016 $3.84M
Total Assets FY 2016 · Dec 31, 2015 $6.49M
Sga Expense FY 2016 · Dec 31, 2016 $6.07M
Sga Expense FY 2016 · Dec 31, 2015 $5.88M
Rd Expense FY 2016 · Dec 31, 2016 $1.48M
Rd Expense FY 2016 · Dec 31, 2015 $1.3M
Net Income FY 2016 · Dec 31, 2016 −$7.41M
Net Income FY 2016 · Dec 31, 2015 −$7.9M
Operating Income FY 2016 · Dec 31, 2016 −$6.67M
Operating Income FY 2016 · Dec 31, 2015 −$7.29M
Gross Profit FY 2016 · Dec 31, 2016 $911.5K
Gross Profit FY 2016 · Dec 31, 2015 $26.8K
Cost Of Revenue FY 2016 · Dec 31, 2016 $1.6M
Cost Of Revenue FY 2016 · Dec 31, 2015 $1.41M
Revenue FY 2016 · Dec 31, 2016 $2.51M
Revenue FY 2016 · Dec 31, 2015 $1.44M